Ignite Creation Date:
2025-12-24 @ 9:59 PM
Ignite Modification Date:
2026-01-01 @ 4:55 PM
Study NCT ID:
NCT01920932
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-12-03
First Post:
2013-08-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Adcetris (Brentuximab Vedotin), Combination Chemotherapy, and Radiation Therapy in Treating Younger Patients With Stage IIB, IIIB and IV Hodgkin Lymphoma
Sponsor:
St. Jude Children's Research Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-08-12
Start Date Type:
ACTUAL
Primary Completion Date:
2020-11-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2028-05
Completion Date Type:
ESTIMATED
First Submit Date:
2013-08-06
First Submit QC Date:
None
Study First Post Date:
2013-08-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-10-13
Results First Submit QC Date:
None
Results First Post Date:
2022-02-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-17
Last Update Post Date:
2025-12-03
Last Update Post Date Type:
ESTIMATED